Welcome to our dedicated page for Nanophase Tech news (Ticker: NANX), a resource for investors and traders seeking the latest updates and insights on Nanophase Tech stock.
Introduction to Nanophase Tech
Nanophase Tech (NANX) is recognized for its integrated approach to nanomaterial technologies, leveraging a platform of patented, scientifically driven innovations tailored for a broad array of industrial and consumer applications. With a firm foundation in nanomaterials, surface finishing, and mineral-based healthcare solutions, the company transforms raw scientific breakthroughs into practical, commercially scalable products.
Core Business and Technology Integration
Established in 1989 and having gone public in 1997, Nanophase Tech has evolved from a pure nanoparticle producer into a comprehensive integrator of engineered nanomaterials. The company develops, manufactures, and markets a broad portfolio of products aimed at improving the performance and aesthetic properties of surfaces, textiles, plastics, and coatings. Additionally, their technologically advanced processes are now applied in personal care and healthcare solutions, capitalizing on the unique properties of mineral-based ingredients that deliver superior performance in sun and environmental protection.
At the heart of its business model lies a commitment to scientific accuracy and innovation. By integrating manufacturing with dedicated research and development laboratories, Nanophase Tech creates products that are not only high performance but also consistent in quality. The company harnesses proprietary technology to offer tailored solutions designed to meet the specific needs of customers operating in varied market segments.
Market Applications and Product Diversity
Nanophase Tech serves a multitude of industries through its engineered nanomaterials, which are applied in:
- Surface Finishing and Coatings: Improving durability, scratch resistance, and aesthetic appeal in exterior coatings and industrial finishes.
- Personal Care: Enabling the formulation of cosmetic and skincare products that offer enhanced UV protection and environmental defense with scientifically driven mineral-based actives.
- Plastics and Textiles: Contributing to advanced material applications that demand improved performance and longevity.
By tailoring their engineered materials as either individual ingredients or as parts of fully formulated products, the company effectively meets the diverse needs of various market sectors. The wide-ranging applications underscore its flexible, integrated approach to nanomaterial innovation.
Scientific Legacy and Quality Assurance
The company's commitment to quality is reflected in its adherence to internationally recognized standards. With manufacturing and corporate facilities located in Romeoville and Burr Ridge, Illinois, both certified under ISO 9001:2008 and ISO 14001:2004, Nanophase Tech maintains rigorous quality control and environmental management practices. This robust quality infrastructure ensures that every product meets stringent performance and reliability standards, bolstering customer confidence and enhancing market reputation.
Innovative Advancements and Rebranding Evolution
In a strategic evolution that underscores its commitment to innovation, the company has rebranded and introduced the Solésence identity, a move that expands its footprint in the beauty and personal care sectors. Under this new banner, the company capitalizes on years of accumulated scientific expertise to drive transformative healthcare solutions, particularly in the realm of skin health. Solésence technologies emphasize advanced formulations that merge efficacy with aesthetics, addressing market needs for inclusive and next-generation consumer products.
Integrated Manufacturing and Operational Excellence
Operational excellence is a cornerstone of Nanophase Tech's business model. The company's dual-location manufacturing operations ensure a seamless integration of production processes with research and development. This sophisticated operational model empowers the company to consistently deliver products at commercial scales while maintaining high degrees of consistency and quality. Such operational robustness is critical in a competitive landscape where precision engineering and scalability are key determinants of market success.
Competitive Position and Market Dynamics
Nanophase Tech's positioning within the industry is defined by its unique synthesis of scientific innovation and commercial execution. Unlike competitors that may focus solely on either production or research, Nanophase Tech offers a holistic approach—integrating end-to-end capabilities from product development to scalable manufacturing. This integrated structure not only optimizes product performance but also facilitates fast adaptation to evolving market demands. The company's diverse applications and established expertise enable it to address challenges inherent to rapidly evolving technological and market landscapes.
Commitment to Scientific Excellence
Every facet of Nanophase Tech's operations is underpinned by a rigorous scientific approach. Its development process involves continuous research, fine-tuning of engineering practices, and adoption of best practices in quality assurance. This commitment to scientific excellence reinforces the company's reputation as a trusted innovator in nanomaterial and mineral-based solutions. By fostering collaborative research and maintaining state-of-the-art laboratories, Nanophase Tech ensures that its products remain at the forefront of technological advances, thereby delivering consistent, high-quality results.
Concluding Overview
In summary, Nanophase Tech is an exemplar of how advanced nanomaterial technologies can be effectively harnessed to address diverse market needs. Its robust integration of research, manufacturing, and commercial applications positions it as a well-versed and multifaceted technology integrator. With an unwavering commitment to quality, extensive product diversity, and a strategic rebranding that signals broader market engagement, Nanophase Tech continues to set benchmarks in both industrial and consumer markets. Investors and industry analysts alike recognize the company's deep scientific expertise, operational excellence, and its capacity to translate complex nanomaterial processes into viable, market-ready products.
Solésence (OTCQB: NANX) has received approval to uplist from OTCQB to the Nasdaq Capital Market, with trading scheduled to begin on Tuesday, April 8, 2025, under the new ticker symbol 'SLSN'. The company, a leader in scientifically-driven health care solutions across beauty and life science categories, met all applicable requirements for Nasdaq listing.
The uplisting process requires no action from current shareholders. CEO Jess Jankowski emphasized that this move is expected to increase visibility within the investment community, broaden the shareholder base, and enhance stakeholder value. COO Kevin Cureton highlighted that this achievement stems from the team's efforts to achieve profitability, successful brand partnerships driving above-industry growth rates, and shareholder support.
Solésence (OTCQB: NANX) reported strong financial results for Q4 and full-year 2024. Fourth quarter revenue reached a record $12.6 million, up 58% year-over-year, with gross profit increasing 460% to $2.8 million. Q4 gross margin improved to 22% from 6% in 2023, though the company recorded a net loss of $0.6 million.
Full-year 2024 performance showed significant growth with revenue up 40% to $52.3 million. Gross profit more than doubled to $16.2 million, with margins expanding to 31%. The company achieved net income of $4.2 million, compared to a $4.4 million loss in 2023.
Operational highlights include doubled production capacity in Q4 2024, expanded batch-making capabilities supporting over $200 million in annual revenue potential, and the launch of over two dozen new SKUs. The company plans to pursue a NASDAQ uplisting in 2025 and is searching for a dedicated CFO.
Solésence (OTCQB: NANX), a healthcare solutions provider specializing in beauty and life science categories, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement. The company will release results after market close on Wednesday, March 26, 2025, followed by a conference call and webcast on Thursday, March 27, 2025 at 7:00 a.m. CDT (8:00 a.m. EDT).
The conference call will feature presentations from President & CEO Jess Jankowski and COO Kevin Cureton. Investors can access the webcast through the company's investor relations website or register for the dial-in option.
Solésence (OTCQB: NANX) has secured its third consecutive win at the 2025 Cosmetics & Toiletries Allē Awards, earning the Best Prestige Finished Formula category for their Au Lait Face Milk SPF 50+ featuring Solésence Kleair™ technology.
The award-winning product is an 18-shade range designed to accommodate all primary skin tones and undertones, while meeting global standards including EU microplastics-free regulations. This follows their 2024 win for Soft Glow SPF 50+ and 2022 recognition for Kleair™ technology as best sun protection ingredient.
The product was evaluated on multiple criteria including:
- Novelty and practicality
- Sustainability
- Safety
- Stability
- Proof of efficacy
Solésence (OTCQB: NANX) has launched a new investor relations website at ir.solesence.com, following its recent rebranding from Nanophase Technologies The website serves as a centralized hub for beauty industry investors and partners to access company financial information and skin health solutions.
The rebranding reflects the company's successful beauty science platform, which has been advancing mineral-based sun and environmental protection since 2015 and driving strategic growth since 2020. The new platform includes comprehensive information such as detailed financial reports, historic Nanophase financials and disclosures, leadership team profiles, and company news.
Nanophase Technologies (OTCQB: NANX) has announced its rebranding as Solésence, Inc., highlighting its focus on mineral-based and scientifically-driven health care solutions in beauty and life science. The rebranding builds on the success of their beauty science platform, which has been driving strategic growth since 2020 through their patented Active Stress Defense™ Technology.
Since their first brand partner product launch in 2018, Solésence has supported numerous beauty brands globally across skin care, sun care, and color cosmetics categories. The company integrates skin health benefits into beauty products while maintaining its commitment to innovation, self-expression, and inclusivity in skin health.
The company will continue trading under the NANX ticker, with its corporate website transitioning to solesence.com. Historic financials and disclosures will remain available at nanophase.com during the transition period.
Nanophase Technologies reported record financial results for Q3 2024, with revenue reaching $16.9 million, a 112% increase from Q3 2023. The company's Solésence subsidiary achieved $13.6 million in revenue, up 171% year-over-year. Q3 gross profit hit a record $6.1 million, with net income of $3 million compared to a $1.4 million loss in Q3 2023.
For the nine months ended September 30, revenue reached $39.8 million, exceeding full-year 2023 revenue by $2.5 million. The company expanded operations by adding three new ISO 6 clean rooms and implementing additional automation across key processes.
Nanophase Technologies (OTCQB: NANX) has announced its Third Quarter 2024 financial results release and conference call schedule. The company will release financial results after market close on October 30, 2024, followed by an investor conference call on October 31, 2024 at 1:00 p.m. CDT. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton discussing financial results and providing business updates. The company specializes in mineral-based healthcare solutions for beauty and life science categories, focusing on skin protection and medical diagnostics.
Nanophase Technologies (OTCQB: NANX) reported record financial results for Q2 2024, with revenue reaching $13 million, a 10% increase from Q2 2023. The company's Solésence subsidiary saw a 44% year-over-year revenue increase to $11.2 million. Net income for Q2 was $856,000, a 157% increase from the same period last year.
For the first half of 2024, Nanophase reported revenue of $22.9 million, a 7% increase from H1 2023. Net income for H1 2024 was $1.7 million, compared to a net loss of $0.8 million in H1 2023. The company also won its third consecutive Cosmopack North America Formulation Award for its Lip Oil SPF 40+ product.
Nanophase Technologies (OTCQB: NANX), a leader in mineral-based health care solutions, has announced its Second Quarter 2024 financial release and conference call details. The company will release its financial news after market close on Tuesday, August 6, 2024, followed by an investor conference call on Wednesday, August 7, 2024, at 11:00 a.m. CDT.
The call will feature Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer. Participants can register for the call to receive dial-in information and a personalized PIN. A listen-only webcast and replay option will also be available through the company's website.
Nanophase Technologies specializes in minerals-based solutions for beauty and life science categories, as well as advanced materials applications, leveraging patented technologies to create unique performance products.
FAQ
What is the current stock price of Nanophase Tech (NANX)?
What is the market cap of Nanophase Tech (NANX)?
What is the core business of Nanophase Tech?
How does Nanophase Tech integrate its technology across multiple markets?
Which industries does Nanophase Tech serve?
What role do its certifications play in the company?
How does the rebranding to Solésence reflect the company's evolution?
What differentiates Nanophase Tech from its competitors?
How does Nanophase Tech maintain its focus on innovation?
